In a landmark decision set to transform the treatment landscape for bladder cancer, the US Food and Drug Administration...
Read MoreA new transatlantic partnership is taking aim at one of the most pressing challenges in oncology – the treatment...
Read MoreUCB has unveiled compelling new three-year data from its phase 3 clinical trials and open-label extensions investigating BIMZELX® (bimekizumab)...
Read MoreLevicept has unveiled compelling new data from its Phase 2 clinical trial of LEVI-04, a first-in-class biologic designed to...
Read MoreIn a landmark decision set to benefit millions across the UK, the National Institute for Health and Care Excellence...
Read MoreIn a move welcomed by both clinicians and patient advocacy groups, the National Institute for Health and Care Excellence...
Read More